Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06169592 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

Study acronym: VORTAL
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Nov 14, 2025 to Nov 14, 2026
    • Study completion date: Apr 14, 2026 to Dec 16, 2026
    v5
  2. Primary completion date: Aug 14, 2025 to Nov 14, 2025
    • Study completion date: Sep 14, 2025 to Apr 14, 2026
    v4
  3. Primary completion date: Aug 14, 2024 to Aug 14, 2025
    • Study completion date: Sep 14, 2024 to Sep 14, 2025
    v3
  4. Primary completion date: Mar 14, 2024 to Aug 14, 2024
    • Study completion date: Mar 14, 2024 to Sep 14, 2024
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.
Trial Details
NCT Number NCT06169592
Lead Sponsor Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov
Conditions
(from sponsor)		 Liver Cirrhosis, Liver Transplant; Complications
Related terms Liver Cirrhosis
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov